Cargando…

One-year safety and efficacy of intravenous etelcalcetide in patients on hemodialysis with secondary hyperparathyroidism

Detalles Bibliográficos
Autores principales: Bushinsky, David A, Chertow, Glenn M, Cheng, Sunfa, Deng, Hongjie, Kopyt, Nelson, Martin, Kevin J, Rastogi, Anjay, Ureña-Torres, Pablo, Vervloet, Marc, Block, Geoffrey A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7473800/
https://www.ncbi.nlm.nih.gov/pubmed/31093680
http://dx.doi.org/10.1093/ndt/gfz111
_version_ 1783579237276450816
author Bushinsky, David A
Chertow, Glenn M
Cheng, Sunfa
Deng, Hongjie
Kopyt, Nelson
Martin, Kevin J
Rastogi, Anjay
Ureña-Torres, Pablo
Vervloet, Marc
Block, Geoffrey A
author_facet Bushinsky, David A
Chertow, Glenn M
Cheng, Sunfa
Deng, Hongjie
Kopyt, Nelson
Martin, Kevin J
Rastogi, Anjay
Ureña-Torres, Pablo
Vervloet, Marc
Block, Geoffrey A
author_sort Bushinsky, David A
collection PubMed
description
format Online
Article
Text
id pubmed-7473800
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-74738002020-09-09 One-year safety and efficacy of intravenous etelcalcetide in patients on hemodialysis with secondary hyperparathyroidism Bushinsky, David A Chertow, Glenn M Cheng, Sunfa Deng, Hongjie Kopyt, Nelson Martin, Kevin J Rastogi, Anjay Ureña-Torres, Pablo Vervloet, Marc Block, Geoffrey A Nephrol Dial Transplant Errata Oxford University Press 2019-05-15 /pmc/articles/PMC7473800/ /pubmed/31093680 http://dx.doi.org/10.1093/ndt/gfz111 Text en © The Author(s) 2019. Published by Oxford University Press on behalf of ERA-EDTA. http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Errata
Bushinsky, David A
Chertow, Glenn M
Cheng, Sunfa
Deng, Hongjie
Kopyt, Nelson
Martin, Kevin J
Rastogi, Anjay
Ureña-Torres, Pablo
Vervloet, Marc
Block, Geoffrey A
One-year safety and efficacy of intravenous etelcalcetide in patients on hemodialysis with secondary hyperparathyroidism
title One-year safety and efficacy of intravenous etelcalcetide in patients on hemodialysis with secondary hyperparathyroidism
title_full One-year safety and efficacy of intravenous etelcalcetide in patients on hemodialysis with secondary hyperparathyroidism
title_fullStr One-year safety and efficacy of intravenous etelcalcetide in patients on hemodialysis with secondary hyperparathyroidism
title_full_unstemmed One-year safety and efficacy of intravenous etelcalcetide in patients on hemodialysis with secondary hyperparathyroidism
title_short One-year safety and efficacy of intravenous etelcalcetide in patients on hemodialysis with secondary hyperparathyroidism
title_sort one-year safety and efficacy of intravenous etelcalcetide in patients on hemodialysis with secondary hyperparathyroidism
topic Errata
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7473800/
https://www.ncbi.nlm.nih.gov/pubmed/31093680
http://dx.doi.org/10.1093/ndt/gfz111
work_keys_str_mv AT bushinskydavida oneyearsafetyandefficacyofintravenousetelcalcetideinpatientsonhemodialysiswithsecondaryhyperparathyroidism
AT chertowglennm oneyearsafetyandefficacyofintravenousetelcalcetideinpatientsonhemodialysiswithsecondaryhyperparathyroidism
AT chengsunfa oneyearsafetyandefficacyofintravenousetelcalcetideinpatientsonhemodialysiswithsecondaryhyperparathyroidism
AT denghongjie oneyearsafetyandefficacyofintravenousetelcalcetideinpatientsonhemodialysiswithsecondaryhyperparathyroidism
AT kopytnelson oneyearsafetyandefficacyofintravenousetelcalcetideinpatientsonhemodialysiswithsecondaryhyperparathyroidism
AT martinkevinj oneyearsafetyandefficacyofintravenousetelcalcetideinpatientsonhemodialysiswithsecondaryhyperparathyroidism
AT rastogianjay oneyearsafetyandefficacyofintravenousetelcalcetideinpatientsonhemodialysiswithsecondaryhyperparathyroidism
AT urenatorrespablo oneyearsafetyandefficacyofintravenousetelcalcetideinpatientsonhemodialysiswithsecondaryhyperparathyroidism
AT vervloetmarc oneyearsafetyandefficacyofintravenousetelcalcetideinpatientsonhemodialysiswithsecondaryhyperparathyroidism
AT blockgeoffreya oneyearsafetyandefficacyofintravenousetelcalcetideinpatientsonhemodialysiswithsecondaryhyperparathyroidism